Carmen Berasain

8.5k total citations
106 papers, 5.6k citations indexed

About

Carmen Berasain is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Carmen Berasain has authored 106 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 30 papers in Hepatology and 28 papers in Epidemiology. Recurrent topics in Carmen Berasain's work include Liver Disease Diagnosis and Treatment (21 papers), Liver physiology and pathology (20 papers) and RNA modifications and cancer (20 papers). Carmen Berasain is often cited by papers focused on Liver Disease Diagnosis and Treatment (21 papers), Liver physiology and pathology (20 papers) and RNA modifications and cancer (20 papers). Carmen Berasain collaborates with scholars based in Spain, United States and Italy. Carmen Berasain's co-authors include Matías A. Ávila, Jesús Prìeto, María U. Latasa, Josefa Castillo, María J. Perugorria, Jaione Valle, Íñigo Lasa, Elena R. García–Trevijano, Bruno Sangro and Maite G. Fernández‐Barrena and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Carmen Berasain

104 papers receiving 5.5k citations

Peers

Carmen Berasain

EPIDE

HEPAT

ONCOL

Takahiro Kodama Japan

Yoshitake Hayashi Japan

Kazushi Sugimoto Japan

Pavel Strnad Germany

Martina Müller Germany

Bård Smedsrød Norway

Elke Roeb Germany

Hui‐Ling Chen Taiwan

Curt H. Hagedorn United States

Manuel López‐Cabrera Spain

Takahiro Kodama Japan

Carmen Berasain

2.4k ×0.8

1.3k ×1.1

EPIDE

884 ×0.8

HEPAT

824 ×0.8

ONCOL

895 ×1.2

Citations per year, relative to Carmen Berasain Carmen Berasain (= 1×) peers Takahiro Kodama

Countries citing papers authored by Carmen Berasain

Since Specialization

Citations

This map shows the geographic impact of Carmen Berasain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Berasain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Berasain more than expected).

Fields of papers citing papers by Carmen Berasain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Berasain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Berasain. The network helps show where Carmen Berasain may publish in the future.

Co-authorship network of co-authors of Carmen Berasain

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Berasain. A scholar is included among the top collaborators of Carmen Berasain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Berasain. Carmen Berasain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Romero, Marta R., Ahmed Ghallab, Rocı́o I.R. Macı́as, et al.. (2025). Gut-to-bile transfer of microbially amidated minor bile acids in patients with hepatopancreatobiliary disorders. Hepatology. 1 indexed citations

Arechederra, María, Maite G. Fernández‐Barrena, Carmen Berasain, & Matías A. Ávila. (2024). Mouse models of primary sclerosing cholangitis: we just can’t get enough. 4(4). 1 indexed citations

Arechederra, María, María Rullán, Daniel Oyón, et al.. (2024). Bile as a liquid biopsy matrix: potential applications and limitations. SHILAP Revista de lepidopterología. 5–21. 3 indexed citations

Elizalde, María Mercedes, Elizabeth Guruceaga, María U. Latasa, et al.. (2024). Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis. JHEP Reports. 6(8). 101118–101118. 1 indexed citations

Macı́as, Rocı́o I.R., Hiroaki Kanzaki, Carmen Berasain, et al.. (2024). The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance. American Journal Of Pathology. 195(3). 422–436. 2 indexed citations

Herranz, José M., Iker Uriarte, María U. Latasa, et al.. (2023). Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD. Journal of Physiology and Biochemistry. 79(4). 901–924. 8 indexed citations

Herranz, José M., María Elizalde, Juan P. Unfried, et al.. (2022). DNA Methylation Regulates a Set of Long Non-Coding RNAs Compromising Hepatic Identity during Hepatocarcinogenesis. Cancers. 14(9). 2048–2048. 6 indexed citations

Arechederra, María, et al.. (2021). Epigenetics in hepatoblastoma. Hepatoma Research.

Yu, Allen T., Carmen Berasain, Sonam Bhatia, et al.. (2021). PHAROH lncRNA regulates Myc translation in hepatocellular carcinoma via sequestering TIAR. eLife. 10. 17 indexed citations

10.

Colyn, Leticia, Iker Uriarte, María U. Latasa, et al.. (2020). Dual Pharmacological Targeting of HDACs and PDE5 Inhibits Liver Disease Progression in a Mouse Model of Biliary Inflammation and Fibrosis. Cancers. 12(12). 3748–3748. 12 indexed citations

11.

Morón‐Ros, Samantha, Iker Uriarte, Carmen Berasain, et al.. (2020). FGF15/19 is required for adipose tissue plasticity in response to thermogenic adaptations. Molecular Metabolism. 43. 101113–101113. 32 indexed citations

12.

Urtasun, Raquel, María Elizalde, María U. Latasa, et al.. (2016). Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression. Oncogene. 35(36). 4719–4729. 25 indexed citations

13.

Berasain, Carmen & Matías A. Ávila. (2015). Regulation of hepatocyte identity and quiescence. Cellular and Molecular Life Sciences. 72(20). 3831–3851. 42 indexed citations

14.

Fernández‐Barrena, Maite G., María J. Monte, María U. Latasa, et al.. (2011). Lack of Abcc3 expression impairs bile-acid induced liver growth and delays hepatic regeneration after partial hepatectomy in mice. Journal of Hepatology. 56(2). 367–373. 35 indexed citations

15.

Perugorria, María J., Josefa Castillo, María U. Latasa, et al.. (2009). Wilms' Tumor 1 Gene Expression in Hepatocellular Carcinoma Promotes Cell Dedifferentiation and Resistance to Chemotherapy. Cancer Research. 69(4). 1358–1367. 46 indexed citations

16.

Tirapu, Iñigo, Eduardo Huarte, Cristiana Guiducci, et al.. (2006). Low Surface Expression of B7-1 (CD80) Is an Immunoescape Mechanism of Colon Carcinoma. Cancer Research. 66(4). 2442–2450. 116 indexed citations

17.

Íñiguez, María, Carmen Berasain, Eduardo Martínez‐Ansó, et al.. (2006). Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. The Journal of Experimental Medicine. 203(13). 2809–2815. 54 indexed citations

18.

Berasain, Carmen, Joaquín Fernández‐Irigoyen, Esther Larrea, et al.. (2004). Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1690(3). 276–284. 35 indexed citations

19.

Berasain, Carmen, et al.. (2000). Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology. Gut. 47(3). 429–435. 96 indexed citations

20.

Berasain, Carmen, Marta García‐Granero, José Ignacio Riezu‐Boj, et al.. (1993). Detection of anti-hepatitis C virus antibodies by ELISA using synthetic peptides. Journal of Hepatology. 18(1). 80–84. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact